Celcuity stock soars after hours on breakthrough therapy designation for cancer drug
July 18, 2022 at 18:31 PM EDT
Shares of Celcuity Inc. were up 17% at $10.80 after hours as the U.S. Food and Drug Administration granted Breakthrough Therapy designation for a cancer drug.
